Experienced in Diabetic Nephropathy

Dr. Mohammed El

Endocrinology
Mohamed Ali El-Shahawy, M.D., M.H.A., M.P.H.
1500 Duarte Rd, 
Duarte, CA 
Experienced in Diabetic Nephropathy
Mohamed Ali El-Shahawy, M.D., M.H.A., M.P.H.
1500 Duarte Rd, 
Duarte, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Mohammed El is an Endocrinologist in Duarte, California. Dr. El is rated as an Experienced provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are High Potassium Level, End-Stage Renal Disease (ESRD), Gallbladder Disease, Islet Cell Transplantation, and Gastrostomy.

His clinical research consists of co-authoring 11 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has participated in 1 clinical trial in the study of Diabetic Nephropathy.

Specialties
Endocrinology
Licenses
Internal Medicine in CA
Hospital Affiliations
Monterey Park Hospital
Coast Plaza Hospital
Saint Francis Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
LA Care
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
SCAN Health Plan
  • INSURANCE PLAN
  • MEDICARE MAPD
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

Mohamed Ali El-Shahawy, M.D., M.H.A., M.P.H.
1500 Duarte Rd, Duarte, CA 91010
Call: 800-826-4673
Other Locations
City Of Hope Comprehensive Cancer Center-Duarte
1500 Duarte Rd, Duarte, CA 91010
Call: 888-304-3959

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of Lademirsen (SAR339375) for Subcutaneous Injection Administered Every Week in Patients With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of Lademirsen (SAR339375) for Subcutaneous Injection Administered Every Week in Patients With Alport Syndrome
Enrollment Status: Terminated
Publish Date: September 11, 2025
Intervention Type: Drug
Study Drug: Iademirsen
Study Phase: Phase 2
A Phase 2, Open-Label, Basket Study of Atrasentan in Patients With Proteinuric Glomerular Diseases
A Phase 2, Open-Label, Basket Study of Atrasentan in Patients With Proteinuric Glomerular Diseases
Enrollment Status: Active_not_recruiting
Publish Date: August 11, 2025
Intervention Type: Drug
Study Drug: Atrasentan
Study Phase: Phase 2
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Enrollment Status: Completed
Publish Date: June 11, 2025
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
An Extended Access Program to Assess Long Term Safety of Bardoxolone Methyl in Patients With Chronic Kidney Disease
An Extended Access Program to Assess Long Term Safety of Bardoxolone Methyl in Patients With Chronic Kidney Disease
Enrollment Status: Terminated
Publish Date: June 03, 2025
Intervention Type: Drug
Study Drug: Bardoxolone
Study Phase: Phase 3
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Atrasentan in Patients With IgA Nephropathy at Risk of Progressive Loss of Renal Function
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Atrasentan in Patients With IgA Nephropathy at Risk of Progressive Loss of Renal Function
Enrollment Status: Active_not_recruiting
Publish Date: October 15, 2024
Intervention Type: Drug
Study Drug: Atrasentan
Study Phase: Phase 3
A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
Enrollment Status: Completed
Publish Date: April 02, 2024
Intervention Type: Drug
Study Drugs: Daprodustat, Darbepoetin Alpha
Study Phase: Phase 3
Randomized, Multicenter, Double-blind, Parallel-Group, Placebo & Comparator-Controlled Study to Compare the Glycemic Effects, Safety & Tolerability of Metformin Delayed-Release Tablets in Patients With Type 2 Diabetes Mellitus
Randomized, Multicenter, Double-blind, Parallel-Group, Placebo & Comparator-Controlled Study to Compare the Glycemic Effects, Safety & Tolerability of Metformin Delayed-Release Tablets in Patients With Type 2 Diabetes Mellitus
Enrollment Status: Suspended
Publish Date: March 14, 2023
Intervention Type: Drug
Study Drug: Metformin
Study Phase: Phase 3
A Phase 1, Open-Label Study to Evaluate the Safety, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection, Including Its Effect on Renal microRNA-21, in Subjects With Alport Syndrome
A Phase 1, Open-Label Study to Evaluate the Safety, Pharmacodynamics, and Pharmacokinetics of RG-012 for Injection, Including Its Effect on Renal microRNA-21, in Subjects With Alport Syndrome
Enrollment Status: Completed
Publish Date: April 25, 2022
Intervention Type: Drug
Study Phase: Phase 1
A Phase 1b, Multicenter, Open-Label, Adaptive Design Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RGLS4326 Administered Via SC Injection to Patients With Autosomal Dominant Polycystic Kidney Disease
A Phase 1b, Multicenter, Open-Label, Adaptive Design Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RGLS4326 Administered Via SC Injection to Patients With Autosomal Dominant Polycystic Kidney Disease
Enrollment Status: Completed
Publish Date: December 15, 2021
Intervention Type: Drug
Study Drug: RGLS4326
Study Phase: Phase 1
A 52-week Open-label (Sponsor-blind), Randomized, Active-controlled, Parallel-group, Multi-center Study to Evaluate the Efficacy and Safety of Daprodustat Compared to Recombinant Human Erythropoietin in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Initiating Dialysis
A 52-week Open-label (Sponsor-blind), Randomized, Active-controlled, Parallel-group, Multi-center Study to Evaluate the Efficacy and Safety of Daprodustat Compared to Recombinant Human Erythropoietin in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Initiating Dialysis
Enrollment Status: Completed
Publish Date: October 20, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 9 Less Clinical Trials

11 Total Publications

Shorter Digestion Times of Donor Islets Is Associated With Better Islet Graft Function After Islet Transplantation.
Shorter Digestion Times of Donor Islets Is Associated With Better Islet Graft Function After Islet Transplantation.
Journal: Cell transplantation
Published: January 30, 2025
View All 11 Publications
Similar Doctors
Bashar Saad
Distinguished in Diabetic Nephropathy
Dr. Bashar Saad
Endocrinology
Distinguished in Diabetic Nephropathy
Dr. Bashar Saad
Endocrinology

Bashar G. Saad, M.D., Inc

399 E Highland Ave, Ste 227, 
San Bernardino, CA 
 (50.4 miles away)
909-882-1210
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Bashar Saad is an Endocrinologist in San Bernardino, California. Dr. Saad is rated as a Distinguished provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Thyroid Nodule, Toxic Nodular Goiter, Type 2 Diabetes (T2D), and Thyroid Storm. Dr. Saad is currently accepting new patients.

Distinguished in Diabetic Nephropathy
Dr. Diana Echeverry
Endocrinology
Distinguished in Diabetic Nephropathy
Dr. Diana Echeverry
Endocrinology

Office

3621 Martin Luther King Jr Blvd Ste 1, 
Lynwood, CA 
 (7.2 miles away)
310-635-6002
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Diana Echeverry is an Endocrinologist in Lynwood, California. Dr. Echeverry is rated as a Distinguished provider by MediFind in the treatment of Diabetic Nephropathy. Her top areas of expertise are Type 2 Diabetes (T2D), Hypothyroidism, Obesity in Children, and Graves Disease.

Distinguished in Diabetic Nephropathy
Dr. Mahtab Sohrevardi
Endocrinology
Distinguished in Diabetic Nephropathy
Dr. Mahtab Sohrevardi
Endocrinology

Huntington Health Specialty Care Pasadena

55 E California Blvd Ste 204, 
Pasadena, CA 
 (8.5 miles away)
626-397-8323
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Mahtab Sohrevardi is an Endocrinologist in Pasadena, California. Dr. Sohrevardi is rated as an Advanced provider by MediFind in the treatment of Diabetic Nephropathy. Her top areas of expertise are Type 2 Diabetes (T2D), Diabetic Nephropathy, Maturity Onset Diabetes of the Young, and Thyroid Storm.

VIEW MORE DIABETIC NEPHROPATHY DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. El's expertise for a condition
ConditionClose
    • Distinguished
    • End-Stage Renal Disease (ESRD)
      Dr. El is
      Distinguished
      . Learn about End-Stage Renal Disease (ESRD).
      See more End-Stage Renal Disease (ESRD) experts
    • High Potassium Level
      Dr. El is
      Distinguished
      . Learn about High Potassium Level.
      See more High Potassium Level experts
    • Advanced
    • Acute Kidney Failure
      Dr. El is
      Advanced
      . Learn about Acute Kidney Failure.
      See more Acute Kidney Failure experts
    • Alport Syndrome
      Dr. El is
      Advanced
      . Learn about Alport Syndrome.
      See more Alport Syndrome experts
    • Chronic Kidney Disease
      Dr. El is
      Advanced
      . Learn about Chronic Kidney Disease.
      See more Chronic Kidney Disease experts
    • Gallbladder Disease
      Dr. El is
      Advanced
      . Learn about Gallbladder Disease.
      See more Gallbladder Disease experts
    • Islet Cell Transplantation
      Dr. El is
      Advanced
      . Learn about Islet Cell Transplantation.
      See more Islet Cell Transplantation experts
    • Experienced
    • Autosomal Dominant Polycystic Kidney Disease
      Dr. El is
      Experienced
      . Learn about Autosomal Dominant Polycystic Kidney Disease.
      See more Autosomal Dominant Polycystic Kidney Disease experts
    • Colonoscopy
      Dr. El is
      Experienced
      . Learn about Colonoscopy.
      See more Colonoscopy experts
    • Diabetic Nephropathy
      Dr. El is
      Experienced
      . Learn about Diabetic Nephropathy.
      See more Diabetic Nephropathy experts
    • Endoscopy
      Dr. El is
      Experienced
      . Learn about Endoscopy.
      See more Endoscopy experts
    • Focal Segmental Glomerulosclerosis
      Dr. El is
      Experienced
      . Learn about Focal Segmental Glomerulosclerosis.
      See more Focal Segmental Glomerulosclerosis experts
    • Gastrostomy
      Dr. El is
      Experienced
      . Learn about Gastrostomy.
      See more Gastrostomy experts
    View All 20 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.